TrialMolecular therapy : the journal of the American Society of Gene Therapy2013

Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

Senda Ajroud-Driss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.